Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Latin America In-vitro Diagnostics Market: By Product and Services: Reagents and Kits, Instruments, Software and Services; By Technology: Infectious Diseases, Others; By Application; By End Use; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments

Latin America In-vitro Diagnostics Market Outlook

The Latin America in-vitro diagnostics market grew a CAGR of 17.9% during the period 2017-2021. Analysis of human samples offers physicians with vital information to properly diagnose, treat, and prevent illnesses. Several leading companies offer in-vitro diagnostic (IVD) solutions that deliver rapid, sensitive results while minimizing cost and complexity. Modern in-vitro diagnostics (IVDs) enable better diagnosis for prevention and management of infectious and chronic diseases. In-vitro diagnostics can help identify early warning signs and individual risk factors, generating new openings for prevention and early intervention. Some in-vitro diagnostics range beyond the laboratory, hospital or doctor’s office, enabling patients with chronic illnesses to self-monitor and manage their own conditions. These factors are expected to drive market growth.

 

Market Likely to be Driven by Advancements in Technology and Demand for Quality Medical Care

Leading in-vitro diagnostics companies seek growth helpful to business plans; regions such as Latin America offer significant market potential. In developing countries, rising levels of income and standards of living are expected to stimulate a new, health-conscious populace seeking quality medical care, and drive the Latin America In-vitro diagnostics market. Latin America is an important region for in-vitro diagnostics manufacturers, with reagents and instruments being key elements in important nations of the continent, including Brazil, Chile, Argentina, Colombia, Peru and Mexico. Key drivers are expected to be growing population, government insurance, patients that are newly insured, and modernized healthcare facilities.

 

Leading Companies Offering Advanced Solutions Expected to Boost Market Growth

Major companies likely to lead the Latin American Market include:

Abbott – A leading company in pharmaceuticals, nutritionals, devices, and diagnostics. In Latin America, the company leads in immunoassay-based microbiology and molecular microbiology, and competes in all countries in immunoassays.

Danaher – Danaher offers a broad range of products in the diagnostics market, these include analytical instruments, reagents, consumables, software, and services employed in different healthcare settings. The company’s Diagnostics segment is classified into Clinical Lab Diagnostics, Critical Care Diagnostics, and Anatomical & Pathological Diagnostics.

Becton Dickinson (BD) – A leading company that develops, produces and sells instrument systems, medical devices, and reagents. In Latin America, the company specializes in flow cytometry, microbiology, and molecular solutions.

Roche Diagnostics – A key player active in clinical chemistry, urinalysis, point of care (POC), and haematology; it competes in molecular and immunoassays. Roche also leads in IVD and tissue-based cancer diagnostics, and in diabetes management.

Siemens Healthineers – A key player in the domain, the company's diagnostics division includes products for clinical chemistry, haematology, drug testing, immunoassay, coagulation, infectious disease, molecular diagnostics, microbiology, plasma proteins, point-of-care testing, blood gases/electrolytes, and urinalysis.

 

Market Segmentation

By product and services, the Latin America In-vitro diagnostics market is divided into:

  • Reagents and Kits
  • Instruments
  • Software and Services

By technology, the market is classified into:

  • Infectious Diseases (further broken down by type as given below)
    • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Enzyme-Linked Immunospot (ELISPOT)
    • Rapid Tests
    • Radioimmunoassay (RIA)
    • Western Blotting
    • Others
  • Clinical Chemistry (further broken down by type as given below)
    • Basic Metabolic Panels
    • Liver Panels
    • Renal Profiles
    • Lipid Profiles
    • Thyroid Function Panels
    • Electrolyte Panels
    • Specialty Chemical Tests
    • Others
  • Molecular Diagnostics (further broken down by type as given below)
    • Polymerize Chain Reaction (PCR)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Hybridisation
    • DNA Diagnostics
    • Microarray
    • Others
  • Haematology
  • Microbiology
  • Coagulation and Haemostasis
  • Urinalysis
  • Others

By application, the market is classified into:

  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Drug Testing/Pharmacogenomics
  • HIV/Aids
  • Autoimmune Diseases
  • Nephrology
  • Others

By end use, the market is segmented into:

  • Hospital and Clinics
  • Diagnostic Laboratories
  • Point-Of-Care Testing
  • Academic Institutes
  • Others

By country, the market is classified into:

  • Brazil
  • Argentina
  • Mexico
  • Chile
  • Peru
  • Uruguay
  • Others

 

Key Industry Players in the Market

The report presents a detailed analysis of the following key players in the Latin America in-vitro diagnostics market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • F. Hoffmann-La Roche Ltd
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc. 
  • bioMérieux SA
  • WAMA Diagnóstica
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product and Services
  • Technology
  • Application
  • End Use
  • Region
Breakup by Product and Services
  • Reagents and Kits
  • Instruments
  • Software and Services
Breakup by Technology
  • Infectious Diseases
    • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Enzyme-Linked Immunospot (ELISPOT)
    • Rapid Tests
    • Radioimmunoassay (RIA)
    • Western Blotting
    • Others
  • Clinical Chemistry
    • Basic Metabolic Panels
    • Liver Panels
    • Renal Profiles
    • Lipid Profiles
    • Thyroid Function Panels
    • Electrolyte Panels
    • Specialty Chemical Tests
    • Others
  • Molecular Diagnostics
    • Polymerize Chain Reaction (PCR)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Hybridisation
    • DNA Diagnostics
    • Microarray
    • Others
  • Haematology
  • Microbiology
  • Coagulation and Haemostasis
  • Urinalysis
  • Others
Breakup by Application
  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Drug Testing/Pharmacogenomics
  • HIV/Aids
  • Autoimmune Diseases
  • Nephrology
  • Others
Breakup by End Use
  • Hospital and Clinics
  • Diagnostic Laboratories
  • Point-Of-Care Testing
  • Academic Institutes
  • Others
Breakup by Region
  • Brazil
  • Argentina
  • Mexico
  • Chile
  • Peru
  • Uruguay
  • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • F. Hoffmann-La Roche Ltd
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc. 
  • bioMérieux SA
  • WAMA Diagnóstica
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface 
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments  
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Latin America
7    Opportunities and Challenges in the Market
8    Latin America In-Vitro Diagnostics Market Analysis

    8.1    Key Industry Highlights
    8.2    Latin America In-Vitro Diagnostics Historical Market (2017-2021) 
    8.3    Latin America In-Vitro Diagnostics Market Forecast (2022-2027)
    8.4    Latin America In-Vitro Diagnostics Market by Product and Services
        8.4.1    Reagents and Kits
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Instruments
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Software and Services
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
    8.5    Latin America In-Vitro Diagnostics Market by Technology
        8.5.1    Infectious Diseases
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
            8.5.1.4    Breakup by Type
                8.5.1.4.1    Enzyme-Linked Immunosorbent Assay (ELISA)
                8.5.1.4.2    Enzyme-Linked Immunospot (ELISPOT)
                8.5.1.4.3    Rapid Tests
                8.5.1.4.4    Radioimmunoassay (RIA)
                8.5.1.4.5    Western Blotting
                8.5.1.4.6    Others
        8.5.2    Clinical Chemistry
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
            8.5.2.4    Breakup by Type
                8.5.2.4.1    Basic Metabolic Panels
                8.5.2.4.2    Liver Panels
                8.5.2.4.3    Renal Profiles
                8.5.2.4.4    Lipid Profiles
                8.5.2.4.5    Thyroid Function Panels
                8.5.2.4.6    Electrolyte Panels
                8.5.2.4.7    Specialty Chemical Tests
                8.5.2.4.8    Others
        8.5.3    Molecular Diagnostics
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
            8.5.3.4    Breakup by Type
                8.5.3.4.1    Polymerize Chain Reaction (PCR)
                8.5.3.4.2    Isothermal Nucleic Acid Amplification Technology (INAAT)
                8.5.3.4.3    Hybridisation
                8.5.3.4.4    DNA Diagnostics
                8.5.3.4.5    Microarray
                8.5.3.4.6    Others
        8.5.4    Haematology
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2017-2021)
            8.5.4.3    Forecast Trend (2022-2027)
        8.5.5    Microbiology
            8.5.5.1    Market Share
            8.5.5.2    Historical Trend (2017-2021)
            8.5.5.3    Forecast Trend (2022-2027)
        8.5.6    Coagulation and Haemostasis
            8.5.6.1    Market Share
            8.5.6.2    Historical Trend (2017-2021)
            8.5.6.3    Forecast Trend (2022-2027)
        8.5.7    Urinalysis
            8.5.7.1    Market Share
            8.5.7.2    Historical Trend (2017-2021)
            8.5.7.3    Forecast Trend (2022-2027)
        8.5.8    Others
    8.6    Latin America In-Vitro Diagnostics Market by Application
        8.6.1    Infectious Diseases
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Diabetes
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Oncology
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
        8.6.4    Cardiology
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2017-2021)
            8.6.4.3    Forecast Trend (2022-2027)
        8.6.5    Drug Testing/Pharmacogenomics
            8.6.5.1    Market Share
            8.6.5.2    Historical Trend (2017-2021)
            8.6.5.3    Forecast Trend (2022-2027)
        8.6.6    HIV/Aids
            8.6.6.1    Market Share
            8.6.6.2    Historical Trend (2017-2021)
            8.6.6.3    Forecast Trend (2022-2027)
        8.6.7    Autoimmune Diseases
            8.6.7.1    Market Share
            8.6.7.2    Historical Trend (2017-2021)
            8.6.7.3    Forecast Trend (2022-2027)
        8.6.8    Nephrology
            8.6.8.1    Market Share
            8.6.8.2    Historical Trend (2017-2021)
            8.6.8.3    Forecast Trend (2022-2027)
        8.6.9    Others
    8.7    Latin America In-Vitro Diagnostics Market by End Use
        8.7.1    Hospital and Clinics
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2017-2021)
            8.7.1.3    Forecast Trend (2022-2027)
        8.7.2    Diagnostic Laboratories
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2017-2021)
            8.7.2.3    Forecast Trend (2022-2027)
        8.7.3    Point-Of-Care Testing
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2017-2021)
            8.7.3.3    Forecast Trend (2022-2027)
        8.7.4    Academic Institutes
            8.7.4.1    Market Share
            8.7.4.2    Historical Trend (2017-2021)
            8.7.4.3    Forecast Trend (2022-2027)
        8.7.5    Others
    8.8    Latin America In-Vitro Diagnostics Market by Country
        8.8.1    Market Share
            8.8.1.1    Brazil
            8.8.1.2    Argentina
            8.8.1.3    Mexico
            8.8.1.4    Chile
            8.8.1.5    Peru
            8.8.1.6    Uruguay
            8.8.1.7    Others
9    Regional Analysis
    9.1    Brazil
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
    9.2    Argentina
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
    9.3    Mexico
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
    9.4    Chile
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
    9.5    Peru
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
    9.6    Uruguay
        9.6.1    Historical Trend (2017-2021)
        9.6.2    Forecast Trend (2022-2027)
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    F. Hoffmann-La Roche Ltd
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Becton, Dickinson and Company
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Bio-Rad Laboratories, Inc. 
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    bioMérieux SA
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    WAMA Diagnóstica
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Others
12    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    Latin America In-Vitro Diagnostics Market: Key Industry Highlights, 2017 and 2027
2.    Latin America In-Vitro Diagnostics Historical Market: Breakup by Product and Services (USD Million), 2017-2021
3.    Latin America In-Vitro Diagnostics Market Forecast: Breakup by Product and Services (USD Million), 2022-2027
4.    Latin America In-Vitro Diagnostics Historical Market: Breakup by Technology (USD Million), 2017-2021
5.    Latin America In-Vitro Diagnostics Market Forecast: Breakup by Technology (USD Million), 2022-2027
6.    Latin America In-Vitro Diagnostics Historical Market: Breakup by Application (USD Million), 2017-2021
7.    Latin America In-Vitro Diagnostics Market Forecast: Breakup by Application (USD Million), 2022-2027
8.    Latin America In-Vitro Diagnostics Historical Market: Breakup by End Use (USD Million), 2017-2021
9.    Latin America In-Vitro Diagnostics Market Forecast: Breakup by End Use (USD Million), 2022-2027
10.    Latin America In-Vitro Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
11.    Latin America In-Vitro Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Latin America In-Vitro Diagnostics Market Structure.

Key Questions Answered in the Report

The market is projected to grow at a CAGR of 17.9% between 2022 and 2027.

The major drivers of the market include the rising levels of income, rising standards of living, growing population, government insurance, newly insured patients, and modernised healthcare facilities.

Advancements in technology and demand for quality medical care are the key industry trends propelling the market's growth.

The major regions in the industry are North America, Europe, Latin America, Asia Pacific, the Middle East and Africa, among others.

The various products and services in the Latin America in-vitro diagnostics market are reagents and kits, instruments, software and services.

Based on technology, the market is segmented into infectious disease, clinical chemistry, molecular diagnostics, haematology, microbiology, coagulation and haemostasis, and urinalysis, among others.

The major applications of the market are infectious diseases, diabetes, cardiology, oncology, drug testing/pharmacogenomics, HIV/Aids, autoimmune diseases, and nephrology, among others.

The end-uses of the market are hospital and clinics, diagnostic laboratories, point-of-care testing, and academic institutes, among others.

The major players in the Latin America in-vitro diagnostics market are F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, and WAMA Diagnóstica, among others.

Purchase Full Report

Mini Report

$ 2199     $1799
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER